Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Bullboard Posts
Comment by lv_426on Mar 10, 2020 6:04pm
69 Views
Post# 30790596

RE:Shiseido DSCC study was a success adn y'all finding out

RE:Shiseido DSCC study was a success adn y'all finding out
Inv3strr wrote: Shiseido can now market in Japan 'cause they did the 1 study required so maybe 2020 afterall...

Study released for DSCC says it has significant increased compared with placebo... It's a new therapeutic method for treating hair loss... then it says that to show a visible difference for your full head of hair they need to inject in a larger area... 

the study was NOT about making you have a full head of hair... if they wanted to do that, they would have done a different study.

it wasn't trying to optimize the full head of hair.. it just wanted to show what happens if you inject DSCC once at different amounts. Why? cause that's what they wanted to do for the japanese regulations to get moving on to the next phase... 

the study was a success for exactly what they had to do for Japan clinical trials so that they can now go to market and  then when its on the market they can inject any amounts and locations on the head taht they want... not so restrictive. 

 Toho and Tokyo Medical University press releases are optimistic about it. 

Shiseido'd website says they are now going to do future studies ... while its on the market obviously... why not.. someones going to pay for it... finance it along the way...

10+++ new hairs that are thicker and bigger EVERY cm on your head.. that is a lot but its going to be a lot more. 

temproary increases are not a problem if you have a frozen cell vial and your Dr takes a tiny bit of it at a time, and  you get an injection every 6 months to 9 months. Or maybe every 2 years who knows. 

Repeat injections could be the key.. and maybe it was on purpose... fact is Shiseido knows that.... $$$

Shiseido could easily go to market in 2020.... They know something we dont know cause they are not beating a dead horse. 

Also RCI-2 can inject the EXACT amount needed to optimize results. 


Steady on there Lee, you still have to sort out the contract with shiseido. You're still required to complete a trial before milestone are reached
Bullboard Posts